SNHG8 is identified as a key regulator in non-small-cell lung cancer progression sponging to miR-542-3p by targeting CCND1/CDK6 [Erratum]
Chen C, Zhang Z, Li J, Sun Y. Onco Targets Ther. 2018;11: 6081–6090.
On page 6089, the acknowledgment section was not included:
This study was funded by National Natural Science Foundation of China (No 81600217), Natural Science Foundation of Jiangsu Province (BK20160346), Jiangyin Municipal Transformation of Scientific and Technological Achievements Project of China (No JYKJ3308).
Read the original article.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]